Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Phase Forward

Phase Forward is the leading provider of data management solutions for clinical trials and drug safety, offering proven solutions in electronic data capture (EDC), clinical data management (CDM), and adverse event reporting (AER) as either an integrated solution or as stand-alone applications. We are the only company that can offer you the market leading products in data capture, data management, and safety as an integrated solution.


Contact Details:
880 Winter Street
Waltham
Massachusetts
02451
United States of America
Tel:1.888.703.1122
Fax:1.781.890.4848
Email:info@phaseforward.com
WWW:

www.phaseforward.com/




Loading...

Recent Publications by Phase Forward:

Signal detection methodologies to support effective safety management.
The increased focus on the safety of medical products, as well as the...
11th September, 2007
Phase Forward Lincoln Technologies, Waltham, MA 02451, USA. Expert Opin Drug Saf. 2007 Jul;6(4):451-64.
DOI Direct Link

Press Releases on Phase Forward:

BioPortfolio Logo
Reportlinker Adds Data Mining in Drug Development and Translational Medicine 26th October, 2009 Reportlinker
-- Business models and solutions in drug development bioinformatics The mountain of data generated and stored is growing ever-higher. The information content of life science data is
MedAptus Expands Board of Directors 16th April, 2009 MedAptus
BOSTON, April 16 /PRNewswire/ -- MedAptus(R), market leader for charge capture technologies, today announced the addition of two new, independent directors, Linda Beneze and Laurence J. Hagerty, to
Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences 24th March, 2009 Frost & Sullivan
MOUNTAIN VIEW, Calif., March 24 /PRNewswire/ -- Frost & Sullivan, the Growth Partnership Company, honored recipients of its 2009 Excellence in Medical Technologies & Life Sciences Awards at a
Schroder Ventures Life Sciences fund raises over US $400 million for 1st May, 2003 Schroder
  Schroder Ventures Life Sciences fund raises over US $400 million for Third International Life Sciences Fund  London and Boston

BioNews Results for Phase Forward:

Developments for Parkinson's Disease Ignite Investor Enthusiasm
Seeking Alpha:  Nov 16 2009 7:46AM Matching: phase forward
Addex ADX10059 Monotherapy is Effective on GERD Symptoms in Phase IIb Clinical Trial
Genetic Engineering News:  Nov 16 2009 6:48AM Matching: phase forward
Addex ADX10059 Monotherapy is Effective on GERD Symptoms in Phase IIb Clinical Trial Primary and Secondary
PR inside:  Nov 16 2009 6:36AM Matching: phase forward
Merck Announces Completion of Patient Enrollment in Phase III TRA-2P-TIMI 50 Trial of SCH 530348, a Novel, Oral Antiplatelet PAR-1 Inhibitor
Business Wire UK:  Nov 13 2009 1:41PM Matching: phase forward
Drilling Underway on Scadding Gold Project and Trueclaim Exploration Inc. Options More Adjacent Mining Claims
Genetic Engineering News:  Nov 13 2009 8:50PM Matching: phase forward
Promote your company here: BioNewsCast - Press Release Distribution

View more Phase Forward news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 222 times since April 2007, the link to the organisation's website has been followed 34 times

Search for more companies in Waltham

Search for more companies in Massachusetts



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Phase Forward

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.